Fig. 6: Generalisable differences in temporal profiles of blood MX1 and IFI27 expression in diverse respiratory virus challenges.

Individual (data points) and loess smoothed summaries (lines ±95% CI) for (A) standardised blood transcript levels of MX1 and IFI27 over the first 6 days after challenge in selected human respiratory virus challenge models (GSE73072) among participants who develop replicative infection, and (B) over 14 days in an H3N2 influenza human challenge model, among participants with (N = 16) and without (N = 3) replicative infection.